Evidence map›Paper›PMID 34746253›Full record

ReviewFrontiers in cardiovascular medicine2021

Virtual (Computed) Fractional Flow Reserve: Future Role in Acute Coronary Syndromes.

Hazel Arfah Haley, Mina Ghobrial, Paul D Morris, Rebecca Gosling, Gareth Williams, Mark T Mills, Tom Newman, Vignesh Rammohan, Giulia Pederzani, Patricia V Lawford and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Hazel Arfah HaleyDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Mina GhobrialDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Paul D MorrisDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Rebecca GoslingDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Gareth WilliamsDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Mark T MillsDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Tom NewmanDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Vignesh RammohanDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Giulia PederzaniDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Patricia V LawfordDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Rodney HoseDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Julian P GunnDepartment of Infection Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Insigneo · GBUniversity of Sheffield · GBSheffield Teaching Hospitals NHS Foundation Trust · GB

Funding

British Heart Foundation FS/12/85/29869British Heart Foundation FS/16/48/32306British Heart Foundation TG/19/1/34451Wellcome Trust
6 · The paper itself

Abstract

The current management of acute coronary syndromes (ACS) is with an invasive strategy to guide treatment. However, identifying the lesions which are physiologically significant can be challenging. Non-invasive imaging is generally not appropriate or timely in the acute setting, so the decision is generally based upon visual assessment of the angiogram, supplemented in a small minority by invasive pressure wire studies using fractional flow reserve (FFR) or related indices. Whilst pressure wire usage is slowly increasing, it is not feasible in many vessels, patients and situations. Limited evidence for the use of FFR in non-ST elevation (NSTE) ACS suggests a 25% change in management, compared with traditional assessment, with a shift from more to less extensive revascularisation. Virtual (computed) FFR (vFFR), which uses a 3D model of the coronary arteries constructed from the invasive angiogram, and application of the physical laws of fluid flow, has the potential to be used more widely in this situation. It is less invasive, fast and can be integrated into catheter laboratory software. For severe lesions, or mild disease, it is probably not required, but it could improve the management of moderate disease in 'real time' for patients with non-ST elevation acute coronary syndromes (NSTE-ACS), and in bystander disease in ST elevation myocardial infarction. Its practicability and impact in the acute setting need to be tested, but the underpinning science and potential benefits for rapid and streamlined decision-making are enticing.

Indexed as

ACS - ACS/NSTEMIangiogram based FFRcomputed blood flowcoronary artery modellingFFRvFFRvirtual FFR

Identifiers

PMID34746253
PMCPMC8569111
OpenAlexW3209528461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.